Stem Cells for ACL Tears and Meniscus Tears

Blog 01.07.2026

    An ACL and meniscus tear can happen in a split second. An ACL tear can be caused by a sudden impact or a gradual weakening of the ACL. More and more people are turning to stem cells to solve this problem. Stem cells for ACL tears are injected to heal the ACL and decrease inflammation. Stem cell therapy for meniscus tears is injected to grow new tissue in the affected area. Stopping pain and potentially osteoarthritis from developing in the future. There is very little scientific research into stem cells for ACL tears and meniscus tears, and no high level of evidence suggesting stem cell therapy is a safe and effective ACL regeneration treatment option for such injuries. We encourage you to read our summary of the current scientific literature and to consider thoroughly the issues highlighted, before embarking on stem cell therapy for meniscus tears and ACL regeneration treatment. A stem cell is an unspecialized cell with the potential to become any type of specialized cell in the body. Stem cells can develop into:

    - To replace damaged tissues with healthy tissues to heal and regenerate.

    - To change the environment and send signals to other cells to form healthy tissues.

    Mesenchymal stem cells, also known as MSCs, have been used to treat many orthopedic conditions such as fractures, degenerative joint conditions, cartilage damage, and soft tissue injuries to tendons, ligaments, and muscles. This is to replace the scar tissues and regenerate tissues rather than allowing scar tissues to form and not function. There are many different factors at play. Stem cell therapy is a relatively new form of therapy. There is not enough information to know if stem cell therapy is effective.

    What is the Anterior Cruciate Ligament and Meniscus?

    The Anterior Cruciate Ligament (ACL) is one of the vital parts of the knee. It is made of fibrous ligament connecting the tibia and femur bones. It is responsible for stability during knee joint movement while doing any rotational or jumping action. It is a common injury among sportspersons. ACL injury occurs in various forms, such as partial tear, complete tear, meniscus tear, etc.

    The meniscus is a semilunar disk of cartilage situated between the distal femur and proximal tibia on each side of the knee joint. The meniscus has two main roles. First, it helps in weight bearing and secondly acts as a shock-absorbing surface. When one jumps, the force of the impact on the lower extremities has to be absorbed by some structure to prevent trauma to the joint. The meniscus acts as this structure by providing a cushion between the joint and the impact. Meniscal tears are also frequent, yet their ability to heal spontaneously after a repair or injectable therapy is extremely variable. Healing depends on the specific type of tear, its location, the patient’s age, and the underlying biological repair capacity. The inner zone of the meniscus is the most commonly injured; although this area has some blood supply, the amount is minimal. Lesions in this zone usually result in some form of scarring that does not restore normal meniscal structure. Other types of tears, particularly horizontal or complex tears, involve the entire meniscus and are unlikely to heal naturally.

    What Are Stem Cells?

    Stem cells are specialized cells with unique properties that allow them to become other tissues and assist in healing (although their role in human healing remains uncertain). Bone Marrow and Fat are common sources used in Orthopedics. The majority of Orthopedic Providers currently favor using Bone Marrow-derived stem cells over fat-derived stem cells as they generally believe that the Bone Marrow-derived stem cells are more effective. Platelet-rich plasma (PRP), which is rich in growth factors, is also used in conjunction with the procedure.

    Stem cells grown in the lab can divide indefinitely and give rise to almost any cell type in the body. When injected into a damaged area, they are thought to help healing support by: producing new tissue, fighting inflammation, and protecting the tissue around them.

    How ACL Injury Stem Cell Treatment Works

    An ACL injury can leave you with years of instability, pain, and swelling. ACL injuries cause a wide range of symptoms which can last for many years unless action is taken. Common symptoms include instability, pain, and swelling of the knee. There are many ways to ACL regeneration treatment. These issues are associated with microstructural differences within the stem cells for ligament injuries and surrounding joint problems seen on imaging. Stem cells may support the body in overcoming these problems by enabling repair of the ligament, reducing abnormal joint tissue inflammation, and increasing the production of collagen specific to the ACL. While there have been several good quality studies done to answer these issues, the results have been inconsistent, partly because of factors such as the population of patients studied, the time of injection, and the source of stem cells.

    The ACL joins the femur and tibia and helps stabilize the knee during activities like jumping, cutting, and pivoting. It consists of multiple bundles that run in different directions, adding stability to the joint. Repair of ACL tears often is not possible due to the complex tear patterns seen and its poor blood supply. ACL injury stem cell treatment currently involves reconstruction of the ligament. Reconstruction restores the joint’s structural stability, but the native proprioceptive capacity of the knee—sensed by the anatomical position of the leg, rotation of the hip-pelvic complex, direction of the foot landing, and other preparatory actions and reactions—may not be reproduced, and many patients do not return to preinjury activity levels.

    How Stem Cell Therapy for Meniscus Tears Work

    Stem cells could assist healing of meniscal tears in various ways. The menisci are crescent-shaped structures between the femur and tibia, made of fibrocartilage. Their primary role is load-bearing, enabling the knee to accept high-impact forces without injury. They also provide stability as secondary restraints to anterior-posterior movement and rotational stability; maintain fluid distribution; and prevent chondral damage by enhancing the congruency of articular surfaces. However, tears in the vascularized peripheral region can scar rather than regenerate. The meniscal tear affects the contact area biomechanics, reducing the overall joint mechanical properties and thus leading to a more rapid cartilage degeneration and, consequently, osteoarthritis, which justifies meniscal repair.

    Stem cells may support healing by modulating the scarring response to create a repair tissue more similar to native meniscal fibrocartilage. Experimental studies in a sheep model suggest that scarring may be replaced with a stem cell–derived cartilage-like tissue that is better able to tolerate load. This type of treatment is still experimental; its efficacy is not yet established and likely varies by tear type. Other indications include tissue-engineering scaffolds for the replacement of complex meniscal lesions. Initial clinical results show that scaffolds populated with cells appear to perform better than acellular scaffolds.

    What are the Treatments in Use Today

    Current stem cell therapy for meniscus tears and ACL there are three ways that it is injected or seeded for an ACL injury stem cell treatment and meniscus tear stem cell therapy. They are as follows: 1. Stem Cells Injection 2. Platelet Rich Plasma (PRP) Therapy 3. Scaffolding and Cell Culture Therapy. What is injected or seeded into your body are precursor cells (cells like stem cells) or regenerative medicine for knee injuries (cells with some stem cell like characteristics and potentially healing benefits). These clinics classify their procedures as Stem Cell because the intended goal of the procedure is to enhance the body’s own healing processes. Thus, they also call it a stem cell treatment for sports injuries.

    You should consult your doctor if you are considering a new joint. Common examples of replacements are non weight bearing joints. It is unclear if more severe conservative-management failures—such as longer lengthening of the surgical timeline, subsequent surgery, or symptomatic behind-the-knee issues—are predictable, preventable, or treatable—particularly with cell-based injection therapies.

    What to Consider Before Treatment

    Before proceeding with stem cells for ACL tears or a stem cell therapy for meniscus tears, patients need to pose several questions. Has their doctor discussed available treatment options? Are they a good candidate? Are there imaging studies available or planned that can show enough detail? What are their activity goals and expected time for a return to play? What is the cost? Will the stem-cell-enhanced treatment be done in combination with other treatments, such as a graft or repair? If so, what is the preferred timing?

    In addition to basic stem cell injections, there are a number of other cell therapy products which are currently available, or are in development, which may have a greater degree of benefit for a specific condition. Some of these include: Platelet-rich products, which are loaded with growth factors and other bioactive molecules which stimulate repair and regeneration. Cell products that combine cells with a scaffold or matrix, and which are very stimulatory to the body’s repair mechanisms. Clinical outcomes for many of these products are improving but are still limited. If there is high demand for the procedure, paying a reasonable amount for treatment after a thorough evaluation by a surgeon with a large volume of cell-enhanced operative experience is wise.

    stem-cells-for-acl-tears-and-meniscus-tears-zaren-stem-cell

    What are Risks and Benefits

    Stem cells can bring many benefits to the body, such as faster healing time, less pain, and improved movement. Also, an injury is less likely to occur. As with all medical procedures, there are also potential risks and complications to consider. While many studies have been done on animals and humans, we can not rule out the potential for stem cells to be over-stimulating, leading to excessive fibrotic scarring. As with any injection, there is a risk of pain and inflammation at the injection site and an adverse reaction to the injection itself. The body can also have an allergic reaction to the stem cells. Unlike most other therapies currently in use, whether one achieves a benefit from a specific form of stem cell treatment for sports injuries remains uncertain.

    Patients seeking repair or ACL regeneration treatment or meniscus may wish to try one of the available stem cell-based therapies because no particular technique carries a strong benefit over standard ACL or meniscal repair. However, these cells seem more effective at increasing safety and swiftness than restoring strength or ability following an injury. Cell-based injections, platelet-rich plasma, and allogeneic experiences further help in standard recovery from an ACL rupture or meniscal tear.

    What the Research Says

    In recent years, the number of studies on the use of stem cells and related products for treating ACL and meniscus tears has surged. A group of researchers reviewed studies on the use of cell-based injections, platelet-rich plasma (PRP) injections, and meniscus scaffolds. The analysis, which included more than 100 human studies and roughly 60 animal studies, suggests that these therapies have moderate potential. The effect seems strongest for the cell-based injections. PRP injections also hold some promise, especially for ACL healing, but further research is needed. The scaffolds do not yet appear to improve healing in humans.

    So many open questions! Who will benefit from this and who will not? Which cells, how to culture them? Which procedure? There are many unknowns that are unable to be given clear-cut answers. It is a hope to be able to get rid of meniscus removal surgery and at least to reduce the incredible speed at which meniscus scaffolds are being developed. The development of these scaffolds is advancing at an astronomic speed, a speed that is far from being compatible with proper preclinical evaluation in large animal models. In the meantime, more evidence is forthcoming for cell-based therapies, particularly ACL healing, and these support the current clinical application.

    Future Directions

    A few areas may be particularly promising for cell-based therapies, but more work is needed to determine what approach is best and for whom. First, preclinical studies suggest that stem cell-based thermosensitive hydrogels may promote repair of full-thickness traumatic articular cartilage defects in the knee. The authors conclude that adding stem cells in the presence of articular cartilage may better recreate the original joint environment compared to isolated stem cell application. Cell-based thermosensitive hydrogels are not yet in clinical use.

    Second, most combination injection therapies using more than one therapeutic method (e.g. bone marrow aspirate concentrate, stem cells and/or platelet-rich plasma) have not yet been thoroughly investigated to identify the relative contribution of each therapeutic component. One recent series has suggested that without an added scaffold, such injections may rely more on bone marrow aspirate concentrate and less on stem cells for LCA reconstruction. Further work is required in this area before any specific guidance can be given. Virtually all current published work has been based on retrospective cohort studies which are also open to bias. Prior to adopting any of these combinations, prospective observational trials should be completed.

    Third, while ACL is usually reconstructed, including a stem cell product in the graft may improve the healing process. Several authors believe that using stem cell-enhanced scaffolds can help avoid systemic failure in special populations. Expert opinions advocate that stem cells should not be discarded, but the current evidence does not establish a definitive recommendation. Despite these uncertainties, cell-based therapy seems to hold considerable promise.

    Conclusion

    This therapy may be an important part of treating ACL injury, stem cell treatment, and meniscus tear stem cell therapy. The two most common injuries to the knee. The knee does not heal well after injuries to these structures because the blood supply to the area is poor, and stem cells have been shown to promote healing. However, more research is needed in this area, with much still to be learned.

    Tears of the ACL and meniscus are among the most common knee injuries. Due to the relatively poor blood supply to these structures, the body is unable to repair itself, and potentially could lead to further knee injuries or degeneration. Current treatments offer some, but not complete, solutions. Cell-based therapies are being considered, although a lack of understanding of the biology involved and the large number of different treatments available pose challenges. Several approaches based on regenerative medicine for knee injuries are being evaluated, including cell-containing injections, platelet-rich plasma (PRP), and cell-carrying scaffolds.

    For ACL injury stem cell treatment, several mechanisms have been proposed for the potential benefits of stem cells: enhancing the healing of the intra-articular tissue, modulating inflammation processes, producing collagen, and stimulating mechanotransduction. High-level analyses of the clinical evidence are encouraging, but many of the studies have methodological limitations and more trials are necessary. The meniscus has only a limited capacity for healing due to low cellularity in its inner region, and the presence of scar tissue after injury (shown by histological studies) may be a reason why meniscal tears treated with repair do not lead to the return of the normal meniscal structure. At the same time, a collaborative study by the two major cartilage registries suggests that meniscal allografts treated with cells possess better results than those without cells, indicating that a cell-based approach may have some ability to recreate a cartilage-like tissue close to the original structure. The presence of a meniscus is known to significantly reduce the risk of knee osteoarthritis in later life.

    Call Now
    WhatsApp